B-Cell Lymphomas Global Clinical Trials Review, H1, 2014

Date: February 19, 2014
Pages: 193
Price:
US$ 2,500.00 US$ 1,875.00
Offer valid until December 31, 2016!
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B20F85728BDEN
Leaflet:

Download PDF Leaflet

B-Cell Lymphomas Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “B-Cell Lymphomas Global Clinical Trials Review, H1, 2014' provides data on the B-Cell Lymphomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on B-Cell Lymphomas . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating B-Cell Lymphomas . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
B-Cell Lymphomas
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of B-Cell Lymphomas to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of B-Cell Lymphomas to Oncology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of B-Cell Lymphomas
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in B-Cell Lymphomas Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on B-Cell Lymphomas
Jan 29, 2014: Cancer Research UK launches trial of new lymphoma treatment
Dec 10, 2013: Senesco’s Drug Candidate SNS01-T Selectively Kills Cancer Cells and Not Healthy Cells in Disease Models
Dec 06, 2013: Rhizen Pharmaceuticals announces initiation of a “First in Human” Phase-1 trial of RP6530, a dual PI3K delta/gamma inhibitor, in patients with hematological malignancies
Dec 06, 2013: TG Therapeutics Launches Combination Clinical Trial of TG-1101 and Ibrutinib in Patients With Select B-Cell Malignancies
Jun 19, 2013: Senesco Announces Results Of Cohort 2 Of Its SNS01-T Phase Ib/IIa Trial
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
Takeda Pharmaceutical Company Limited
Clinical Trial Overview of Takeda Pharmaceutical Company Limited
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Novartis AG
Clinical Trial Overview of Novartis AG
Biogen Idec Inc.
Clinical Trial Overview of Biogen Idec Inc.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Pharmacyclics, Inc.
Clinical Trial Overview of Pharmacyclics, Inc.
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Janssen Global Services, LLC
Clinical Trial Overview of Janssen Global Services, LLC
Clinical Trial Overview of Top Institutes / Government
National Cancer Institute
Clinical Trial Overview of National Cancer Institute
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Southwest Oncology Group
Clinical Trial Overview of Southwest Oncology Group
Groupe d'Etudes de Lymphomes de L'Adulte
Clinical Trial Overview of Groupe d'Etudes de Lymphomes de L'Adulte
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
City of Hope National Medical Center
Clinical Trial Overview of City of Hope National Medical Center
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

B-Cell Lymphomas Therapeutics, Global, Clinical Trials by Region, 2014*
B-Cell Lymphomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
B-Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
Proportion of B-Cell Lymphomas to Oncology Clinical Trials, G7 Countries (%), 2014*
B-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
B-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
Proportion of B-Cell Lymphomas to Oncology Clinical Trials, E7 Countries (%), 2014*
B-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
B-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
B-Cell Lymphomas Therapeutics, Global, Clinical Trials by Phase, 2014*
B-Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
B-Cell Lymphomas Therapeutics, Global, Clinical Trials by Trial Status, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials, Global, by End Point Status, 2014*
B-Cell Lymphomas Therapeutics, Global, Suspended Clinical Trials, 2014*
B-Cell Lymphomas Therapeutics, Global, Withdrawn Clinical Trials, 2014*
B-Cell Lymphomas Therapeutics, Global, Terminated Clinical Trials, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2014*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 2014*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe d'Etudes de Lymphomes de L'Adulte, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014*
B-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2014*

LIST OF FIGURES

B-Cell Lymphomas Therapeutics, Global, Clinical Trials by Region (%), 2014
B-Cell Lymphomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
B-Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
B-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014
B-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014
B-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries (%), 2014
B-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014
B-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014
Proportion of B-Cell Lymphomas to Oncology Clinical Trials, G7 Countries (%), 2014
B-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
B-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of B-Cell Lymphomas to Oncology Clinical Trials, E7 Countries (%), 2014
B-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Phase, 2014
B-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014
B-Cell Lymphomas Therapeutics, Global, Clinical Trials by Phase (%), 2014
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014
B-Cell Lymphomas Therapeutics, Global, Clinical Trials by Trial Status, 2014
B-Cell Lymphomas Therapeutics Clinical Trials, Global, by End Point Status, 2014
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
B-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2014
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
B-Cell Lymphomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
GlobalData Methodology
Skip to top


Ask Your Question

B-Cell Lymphomas Global Clinical Trials Review, H1, 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: